Concepedia

Weidong Pan

WP

107

Publications

3.6K

Citations

32

H-Index

1995

Active since

Affiliations

Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences(Current)

Guiyang Medical University

Guizhou University

University of Namur

Zunyi Medical University

Weidong Pan is an author at Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences specializing in pharmacology, medicine, and natural sciences.

ORCID

Top concepts

Publications per year

1995–2024

107

Publications

107

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 411 citations

, , +3

Discovery of (1 <i>R</i> ,5 <i>S</i> )- <i>N</i> -[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]- 3-[2( <i>S</i> )-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2( <i>S</i> )-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor:  A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection

Srikanth Venkatraman, Stéphane Bogen, Ashok Arasappan et al. · Journal of Medicinal Chemistry · 2006 · 278 citations · Full text

Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells

Ning Wang, Weidong Pan, Meifen Zhu et al. · British Journal of Pharmacology · 2011 · 144 citations · Full text

RETRACTED: lnc<scp>RNA</scp>‐<scp>PDPK</scp>2P promotes hepatocellular carcinoma progression through the <scp>PDK</scp>1/<scp>AKT</scp>/Caspase 3 pathway

Weidong Pan, Wen Li, Jun Zhao et al. · Molecular Oncology · 2019 · 119 citations · Full text

Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease Inhibitor

Ashok Arasappan, Frank Bennett, Stéphane Bogen et al. · ACS Medicinal Chemistry Letters · 2010 · 95 citations · Full text

, , +11

Rows per page

1–5 of 107